| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | REYNOLDS AMERICAN INC | 16,684,590 | 769,994,000 | 33.04% | ||
| 2 | ABBVIE INC | 8,794,000 | 520,957,000 | 22.35% | ||
| 3 | ALKERMES PLC SHS | 5,535,569 | 439,413,000 | 18.85% | ||
| 4 | PROTHENA CORP PLC | 6,379,661 | 434,519,000 | 18.64% | ||
| 5 | Theravance Biopharma Inc | 5,061,637 | 82,960,000 | 3.56% | ||
| 6 | NORTHWEST BIOTHERAPEUTICS INC | 25,915,937 | 82,931,000 | 3.56% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001213900-17-005680, filed 2017.05.22).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
